These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
241 related items for PubMed ID: 4619681
1. Factors in infectious complications following cadaver renal transplantation. Thomas F, Lee HM, Wolf JS, Thomas J. Proc Clin Dial Transplant Forum; 1973; 3():196-9. PubMed ID: 4619681 [No Abstract] [Full Text] [Related]
2. [Infectious pulmonary complications observed after renal transplantation (analysis of 104 cases)]. Chebat J, Gluckman JC, Legrain M, Kuss R. Ann Med Interne (Paris); 1973 Feb; 124(2):99-105. PubMed ID: 4579389 [No Abstract] [Full Text] [Related]
3. Clinical experience with cardiac transplantation: retrospective considerations. Meere C, Grondin CM, Castonguay Y, Lepage G, Grondin P. Cardiovasc Clin; 1971 Feb; 2(3):277-87. PubMed ID: 4950428 [No Abstract] [Full Text] [Related]
4. In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human. Thomas F, Berry R, Mendez-Picon G, Thomas J, Lower RR, Lee HM. Proc Clin Dial Transplant Forum; 1971 Feb; 8():56-61. PubMed ID: 386321 [No Abstract] [Full Text] [Related]
5. Intermodal immunosuppression for cadaver renal transplantation: results using antilymphocyte globulin, azathioprine, cyclosporine, and prednisone. Halloran P, Ludwin D, Bear R, Aprile M, McQuarrie B, Poole R, White N. Transplant Proc; 1987 Feb; 19(1 Pt 3):1931-2. PubMed ID: 3274454 [No Abstract] [Full Text] [Related]
14. Specific immunosuppression in cardiac allografting using antithymocyte sera and soluble transplantation antigen. Thomas FT, Wolf JS, Thomas JM, Lower RR, Hudson B, Burke S. Ann Thorac Surg; 1974 Sep 24; 18(3):241-9. PubMed ID: 4607085 [No Abstract] [Full Text] [Related]
16. Trends in immunosuppression for kidney transplantation. Butt KM, Zielinski CM, Parsa I, Elberg AJ, Wechter W, Kountz SL. Kidney Int Suppl; 1978 Jun 24; (8):S95-8. PubMed ID: 357820 [No Abstract] [Full Text] [Related]
18. Causes of allograft failure in recipients treated with and without antilymphocyte globulin. Sheil AG, May J, Rogers JH, Storey BG, Katran DC, Duggin GG, Johnson JR, Stewart JH. Transplant Proc; 1973 Mar 24; 5(1):561-5. PubMed ID: 4121179 [No Abstract] [Full Text] [Related]
19. Use of rabbit ATG in cadaver kidney transplantation: an updated report with consideration of presensitized recipients. Davis RC, Nabseth DC, Olsson CA, Idelson BA, Schmitt GW, Cho SI, Mannick JA. Transplant Proc; 1974 Dec 24; 6(4 Suppl 1):67-70. PubMed ID: 4612906 [No Abstract] [Full Text] [Related]
20. A controlled trial antilymphocyte globulin therapy (ALG) in man. Sheil AG, Mears D, Kelly GE, Stewart JH, Johnson JR, Tiller D, Gallery ED, Duggin GG. Transplant Proc; 1972 Dec 24; 4(4):501-5. PubMed ID: 4118965 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]